fda bpc-157 not approved panel backs compounded BPC-157, KPV peptides in win for RFK Jr A step towards expanded patient

A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! An FDA advisory panel voted on BPC 157 today., That does not mean BPC 157 was FDA approved., The panel recommended that BPC 157 be considered for addition to a list of substances that may be used by $HIMS Stock: FDA Panel Recommends BPC 157 Peptide BPC 157 WHY IT WILL NEVER BE FDA APPROVED Stefano M. Sinicropi, MD

SKU: 71986846924 · From www.marsberger-treibhaus.de